reglab/housing_qa huggingface dataset:
MN Stat § 152.136 (2021)
2021 Minnesota Statutes|Chapters 144 - 159 — Health|Chapter 152 — Drugs; Controlled Substances|Section 152.136 — Anhydrous Ammonia; Prohibited Conduct; Criminal Penalties; Civil Liability.

152.136 ANHYDROUS AMMONIA; PROHIBITED CONDUCT; CRIMINAL PENALTIES; CIVIL LIABILITY. Subdivision 1. Definitions. As used in this section, "tamper" means action taken by a person not authorized to take that action by law or by the owner or authorized custodian of an anhydrous ammonia container or of equipment where anhydrous ammonia is used, stored, distributed, or transported. Subd. 2. Prohibited conduct. (a) A person may not: (1) steal or unlawfully take or carry away any amount of anhydrous ammonia; (2) purchase, possess, transfer, or distribute any amount of anhydrous ammonia, knowing, or having reason to know, that it will be used to unlawfully manufacture a controlled substance; (3) place, have placed, or possess anhydrous ammonia in a container that is not designed, constructed, maintained, and authorized to contain or transport anhydrous ammonia; (4) transport anhydrous ammonia in a container that is not designed, constructed, maintained, and authorized to transport anhydrous ammonia; (5) use, deliver, receive, sell, or transport a container designed and constructed to contain anhydrous ammonia without the express consent of the owner or authorized custodian of the container; or (6) tamper with any equipment or facility used to contain, store, or transport anhydrous ammonia. (b) For the purposes of this subdivision, containers designed and constructed for the storage and transport of anhydrous ammonia are described in rules adopted under section 18C.121, subdivision 1, or in Code of Federal Regulations, title 49. Subd. 3. No cause of action. (a) Except as provided in paragraph (b), a person tampering with anhydrous ammonia containers or equipment under subdivision 2 shall have no cause of action for damages arising out of the tampering against: (1) the owner or lawful custodian of the container or equipment; (2) a person responsible for the installation or maintenance of the container or equipment; or (3) a person lawfully selling or offering for sale the anhydrous ammonia. (b) Paragraph (a) does not apply to a cause of action against a person who unlawfully obtained the anhydrous ammonia or anhydrous ammonia container or who possesses the anhydrous ammonia or anhydrous ammonia container for any unlawful purpose. Subd. 4. Criminal penalty. A person who knowingly violates subdivision 2 is guilty of a felony and may be sentenced to imprisonment for not more than five years or to payment of a fine of not more than $50,000, or both. History:   2005 c 136 art 7 s 11
MN Stat § 152.152 (2021)
2021 Minnesota Statutes|Chapters 144 - 159 — Health|Chapter 152 — Drugs; Controlled Substances|Section 152.152 — Stayed Sentence Limited.

152.152 STAYED SENTENCE LIMITED. If a person is convicted under section 152.021, 152.022, 152.023, or 152.0262, and the Sentencing Guidelines grid calls for a presumptive prison sentence for the offense, the court may stay imposition or execution of the sentence only as provided in this section. The sentence may be stayed based on amenability to probation only if the offender presents adequate evidence to the court that the offender has been accepted by, and can respond to, a treatment program that has been approved by the commissioner of human services. The court may impose a sentence that is a mitigated dispositional departure on any other ground only if the court includes as a condition of probation incarceration in a local jail or workhouse. History:  1989 c 290 art 3 s 20; 2005 c 136 art 7 s 21
MN Stat § 152.20 (2021)
2021 Minnesota Statutes|Chapters 144 - 159 — Health|Chapter 152 — Drugs; Controlled Substances|Section 152.20 — Penalties Under Other Laws.

152.20 PENALTIES UNDER OTHER LAWS. Any penalty imposed for violation of this chapter is in addition to, and not in lieu of, any civil or administrative penalty or sanction otherwise authorized by law. History:  1971 c 937 s 20; 1989 c 290 art 3 s 22
MN Stat § 152.205 (2021)
2021 Minnesota Statutes|Chapters 144 - 159 — Health|Chapter 152 — Drugs; Controlled Substances|Section 152.205 — Local Regulations.

152.205 LOCAL REGULATIONS. Sections 152.01, subdivision 18, and 152.092 to 152.095 do not preempt enforcement or preclude adoption of municipal or county ordinances prohibiting or otherwise regulating the manufacture, delivery, possession, or advertisement of drug paraphernalia. History:  1982 c 557 s 11; 1988 c 665 s 1
MN Stat § 152.23 (2021)
2021 Minnesota Statutes|Chapters 144 - 159 — Health|Chapter 152 — Drugs; Controlled Substances|Section 152.23 — Limitations.

152.23 LIMITATIONS. (a) Nothing in sections 152.22 to 152.37 permits any person to engage in and does not prevent the imposition of any civil, criminal, or other penalties for: (1) undertaking any task under the influence of medical cannabis that would constitute negligence or professional malpractice; (2) possessing or engaging in the use of medical cannabis: (i) on a school bus or van; (ii) on the grounds of any preschool or primary or secondary school; (iii) in any correctional facility; or (iv) on the grounds of any child care facility or home day care; (3) vaporizing or combusting medical cannabis pursuant to section 152.22, subdivision 6: (i) on any form of public transportation; (ii) where the vapor would be inhaled by a nonpatient minor child or where the smoke would be inhaled by a minor child; or (iii) in any public place, including any indoor or outdoor area used by or open to the general public or a place of employment as defined under section 144.413, subdivision 1b; and (4) operating, navigating, or being in actual physical control of any motor vehicle, aircraft, train, or motorboat, or working on transportation property, equipment, or facilities while under the influence of medical cannabis. (b) Nothing in sections 152.22 to 152.37 require the medical assistance and MinnesotaCare programs to reimburse an enrollee or a provider for costs associated with the medical use of cannabis. Medical assistance and MinnesotaCare shall continue to provide coverage for all services related to treatment of an enrollee's qualifying medical condition if the service is covered under chapter 256B or 256L. History:  2014 c 311 s 3; 2021 c 30 art 3 s 31
MN Stat § 152.24 (2021)
2021 Minnesota Statutes|Chapters 144 - 159 — Health|Chapter 152 — Drugs; Controlled Substances|Section 152.24 — Federally Approved Clinical Trials.

152.24 FEDERALLY APPROVED CLINICAL TRIALS. The commissioner may prohibit enrollment of a patient in the registry program if the patient is simultaneously enrolled in a federally approved clinical trial for the treatment of a qualifying medical condition with medical cannabis. The commissioner shall provide information to all patients enrolled in the registry program on the existence of federally approved clinical trials for the treatment of the patient's qualifying medical condition with medical cannabis as an alternative to enrollment in the patient registry program. History:   2014 c 311 s 4
MN Stat § 152.26 (2021)
2021 Minnesota Statutes|Chapters 144 - 159 — Health|Chapter 152 — Drugs; Controlled Substances|Section 152.26 — Rulemaking.

152.26 RULEMAKING. (a) The commissioner may adopt rules to implement sections 152.22 to 152.37. Rules for which notice is published in the State Register before January 1, 2015, may be adopted using the process in section 14.389. (b) The commissioner may adopt or amend rules, using the procedure in section 14.386, paragraph (a), to implement the addition of dried raw cannabis as an allowable form of medical cannabis under section 152.22, subdivision 6, paragraph (a), clause (4). Section 14.386, paragraph (b), does not apply to these rules. History:  2014 c 311 s 6; 2021 c 30 art 3 s 32
MN Stat § 152.261 (2021)
2021 Minnesota Statutes|Chapters 144 - 159 — Health|Chapter 152 — Drugs; Controlled Substances|Section 152.261 — Rules; Adverse Incidents.

152.261 RULES; ADVERSE INCIDENTS. (a) The commissioner of health shall adopt rules to establish requirements for reporting incidents when individuals who are not authorized to possess medical cannabis under sections 152.22 to 152.37 are found in possession of medical cannabis. The rules must identify professionals required to report, the information they are required to report, and actions the reporter must take to secure the medical cannabis. (b) The commissioner of health shall adopt rules to establish requirements for law enforcement officials and health care professionals to report incidents involving an overdose of medical cannabis to the commissioner of health. (c) Rules must include the method by which the commissioner will collect and tabulate reports of unauthorized possession and overdose. History:   2014 c 311 s 19
MN Stat § 152.30 (2021)
2021 Minnesota Statutes|Chapters 144 - 159 — Health|Chapter 152 — Drugs; Controlled Substances|Section 152.30 — Patient Duties.

152.30 PATIENT DUTIES. (a) A patient shall apply to the commissioner for enrollment in the registry program by submitting an application as required in section 152.27 and an annual registration fee as determined under section 152.35. (b) As a condition of continued enrollment, patients shall agree to: (1) continue to receive regularly scheduled treatment for their qualifying medical condition from their health care practitioner; and (2) report changes in their qualifying medical condition to their health care practitioner. (c) A patient shall only receive medical cannabis from a registered manufacturer but is not required to receive medical cannabis products from only a registered manufacturer. History:   2014 c 311 s 10
MN Stat § 152.31 (2021)
2021 Minnesota Statutes|Chapters 144 - 159 — Health|Chapter 152 — Drugs; Controlled Substances|Section 152.31 — Data Practices.

152.31 DATA PRACTICES. (a) Government data in patient files maintained by the commissioner and the health care practitioner, and data submitted to or by a medical cannabis manufacturer, are private data on individuals, as defined in section 13.02, subdivision 12, or nonpublic data, as defined in section 13.02, subdivision 9, but may be used for purposes of complying with chapter 13 and complying with a request from the legislative auditor or the state auditor in the performance of official duties. The provisions of section 13.05, subdivision 11, apply to a registration agreement entered between the commissioner and a medical cannabis manufacturer under section 152.25. (b) Not public data maintained by the commissioner may not be used for any purpose not provided for in sections 152.22 to 152.37, and may not be combined or linked in any manner with any other list, dataset, or database. (c) The commissioner may execute data sharing arrangements with the commissioner of agriculture to verify licensing, inspection, and compliance information related to hemp growers and hemp processors under chapter 18K. History:  2014 c 311 s 11; 1Sp2019 c 9 art 11 s 97; 2021 c 30 art 3 s 41
MN Stat § 152.34 (2021)
2021 Minnesota Statutes|Chapters 144 - 159 — Health|Chapter 152 — Drugs; Controlled Substances|Section 152.34 — Health Care Facilities.

152.34 HEALTH CARE FACILITIES. (a) Health care facilities licensed under chapter 144A, hospice providers licensed under chapter 144A, boarding care homes or supervised living facilities licensed under section 144.50, assisted living facilities, facilities owned, controlled, managed, or under common control with hospitals licensed under chapter 144, and other health facilities licensed by the commissioner of health, may adopt reasonable restrictions on the use of medical cannabis by a patient enrolled in the registry program who resides at or is actively receiving treatment or care at the facility. The restrictions may include a provision that the facility will not store or maintain the patient's supply of medical cannabis, that the facility is not responsible for providing the medical cannabis for patients, and that medical cannabis be used only in a place specified by the facility. (b) Any employee or agent of a facility listed in this section or a person licensed under chapter 144E is not subject to violations under this chapter for possession of medical cannabis while carrying out employment duties, including providing or supervising care to a registered patient, or distribution of medical cannabis to a registered patient who resides at or is actively receiving treatment or care at the facility with which the employee or agent is affiliated. Nothing in this section shall require the facilities to adopt such restrictions and no facility shall unreasonably limit a patient's access to or use of medical cannabis to the extent that use is authorized by the patient under sections 152.22 to 152.37. History:  2014 c 311 s 14; 2015 c 74 s 6; 1Sp2019 c 9 art 11 s 101
MN Stat § 152.35 (2021)
2021 Minnesota Statutes|Chapters 144 - 159 — Health|Chapter 152 — Drugs; Controlled Substances|Section 152.35 — Fees; Deposit Of Revenue.

152.35 FEES; DEPOSIT OF REVENUE. (a) The commissioner shall collect an enrollment fee of $200 from patients enrolled under this section. If the patient provides evidence of receiving Social Security disability insurance (SSDI), Supplemental Security Income (SSI), veterans disability, or railroad disability payments, or being enrolled in medical assistance or MinnesotaCare, then the fee shall be $50. For purposes of this section: (1) a patient is considered to receive SSDI if the patient was receiving SSDI at the time the patient was transitioned to retirement benefits by the United States Social Security Administration; and (2) veterans disability payments include VA dependency and indemnity compensation. Unless a patient provides evidence of receiving payments from or participating in one of the programs specifically listed in this paragraph, the commissioner of health must collect the $200 enrollment fee from a patient to enroll the patient in the registry program. The fees shall be payable annually and are due on the anniversary date of the patient's enrollment. The fee amount shall be deposited in the state treasury and credited to the state government special revenue fund. (b) The commissioner shall collect an application fee of $20,000 from each entity submitting an application for registration as a medical cannabis manufacturer. Revenue from the fee shall be deposited in the state treasury and credited to the state government special revenue fund. (c) The commissioner shall establish and collect an annual fee from a medical cannabis manufacturer equal to the cost of regulating and inspecting the manufacturer in that year. Revenue from the fee amount shall be deposited in the state treasury and credited to the state government special revenue fund. (d) A medical cannabis manufacturer may charge patients enrolled in the registry program a reasonable fee for costs associated with the operations of the manufacturer. The manufacturer may establish a sliding scale of patient fees based upon a patient's household income and may accept private donations to reduce patient fees. History:  2014 c 311 s 15; 2020 c 115 art 1 s 13
MN Stat § 152.37 (2021)
2021 Minnesota Statutes|Chapters 144 - 159 — Health|Chapter 152 — Drugs; Controlled Substances|Section 152.37 — Financial Examinations; Pricing Reviews.

152.37 FINANCIAL EXAMINATIONS; PRICING REVIEWS. Subdivision 1. Financial records. A medical cannabis manufacturer shall maintain detailed financial records in a manner and format approved by the commissioner, and shall keep all records updated and accessible to the commissioner when requested. Subd. 2. Certified annual audit. A medical cannabis manufacturer shall submit the results of an annual certified financial audit to the commissioner no later than May 1 of each year for the calendar year beginning January 2015. The annual audit shall be conducted by an independent certified public accountant and the costs of the audit are the responsibility of the medical cannabis manufacturer. Results of the audit shall be provided to the medical cannabis manufacturer and the commissioner. The commissioner may also require another audit of the medical cannabis manufacturer by a certified public accountant chosen by the commissioner with the costs of the audit paid by the medical cannabis manufacturer. Subd. 3. Power to examine. (a) The commissioner or designee may examine the business affairs and conditions of any medical cannabis manufacturer, including but not limited to a review of the financing, budgets, revenues, sales, and pricing. (b) An examination may cover the medical cannabis manufacturer's business affairs, practices, and conditions including but not limited to a review of the financing, budgets, revenues, sales, and pricing. The commissioner shall determine the nature and scope of each examination and in doing so shall take into account all available relevant factors concerning the financial and business affairs, practices, and conditions of the examinee. The costs incurred by the department in conducting an examination shall be paid for by the medical cannabis manufacturer. (c) When making an examination under this section, the commissioner may retain attorneys, appraisers, independent economists, independent certified public accountants, or other professionals and specialists as designees. A certified public accountant retained by the commissioner may not be the same certified public accountant providing the certified annual audit in subdivision 2. (d) The commissioner shall make a report of an examination conducted under this section and provide a copy to the medical cannabis manufacturer. The commissioner shall then post a copy of the report on the department's website. All working papers, recorded information, documents, and copies produced by, obtained by, or disclosed to the commissioner or any other person in the course of an examination, other than the information contained in any commissioner official report, made under this section are private data on individuals or nonpublic data, as defined in section 13.02. History:  2014 c 311 s 17; 2015 c 74 s 10
MN Stat § 153.01 (2021)
2021 Minnesota Statutes|Chapters 144 - 159 — Health|Chapter 153 — Podiatry|Section 153.01 — Definitions.

153.01 DEFINITIONS. Subdivision 1. Words, terms, and phrases. Unless the language or context clearly indicates that a different meaning is intended, the following words, terms, and phrases, for the purposes of this chapter, shall be given the meanings subjoined to them. Subd. 2. Podiatric medicine. "Podiatric medicine" means the diagnosis or medical, mechanical, or surgical treatment of the ailments of the human hand, foot, ankle, and the soft tissue of the lower leg distal to the tibial tuberosity. Medical or surgical treatment includes partial foot amputation and excludes amputation of the hand or fingers. Use of local anesthetics is within the scope of medical and surgical management in patient care. Use of anesthetics, other than local, is excluded, except as provided in section 153.26. Podiatric medicine includes the prescribing or recommending of appliances, devices, or shoes for the correction or relief of foot ailments. Podiatric medicine includes the prescribing or administering of any drugs or medications necessary or helpful to the practice of podiatric medicine as defined by this subdivision. For a podiatrist who has completed a residency, podiatric medicine includes the performance of all or part of the medical history and physical examination for the purpose of hospital admission for podiatric management or preoperative podiatric surgery. Subd. 3. Board. "Board" means the Board of Podiatric Medicine of the state of Minnesota. Subd. 4.  [Repealed, 1987 c 108 s 17] History:  (5769, 5783) 1917 c 382 s 2,16; 1935 c 266 s 1; 1957 c 192 s 1; 1959 c 70 s 1; 1961 c 369 s 2; 1973 c 693 s 19; 1975 c 271 s 6; 1987 c 108 s 1,2; 1990 c 540 s 1; 2004 c 279 art 8 s 1
MN Stat § 153.02 (2021)
2021 Minnesota Statutes|Chapters 144 - 159 — Health|Chapter 153 — Podiatry|Section 153.02 — Board Of Podiatric Medicine.

153.02 BOARD OF PODIATRIC MEDICINE. The governor shall appoint a Board of Podiatric Medicine consisting of two public members as defined by section 214.02 and five resident podiatrists. The podiatrists must each hold a degree of doctor of podiatric medicine and be licensed to practice podiatric medicine under this chapter. Membership terms, compensation of members, removal of members, the filling of membership vacancies, and fiscal year and reporting requirements shall be as provided in sections 214.07 to 214.09. The provision of staff, administrative services and office space; the review and processing of complaints; the setting of board fees; and other provisions related to board operations shall be as provided in chapter 214. The board shall elect from among its members a president and a secretary-treasurer. The board may adopt rules as necessary to carry out the purposes of this chapter. The members of the board may administer oaths and take testimony as to matters pertaining to the duties of the board. Four members of the board shall constitute a quorum for the transaction of business. The board shall have a common seal, which shall be kept by the executive director. History:  (5770) 1917 c 382 s 3; 1961 c 369 s 1; 1973 c 638 s 31; 1975 c 136 s 32; 1975 c 271 s 6; 1976 c 222 s 96; 1976 c 239 s 59; 1987 c 108 s 3; 1991 c 199 art 1 s 46
MN Stat § 153.03 (2021)
2021 Minnesota Statutes|Chapters 144 - 159 — Health|Chapter 153 — Podiatry|Section 153.03 — Expenses.

153.03 EXPENSES. The expenses of administering Laws 1987, chapter 108, sections 1 to 16, shall be paid from the appropriations made to the board. History:  (5771) 1917 c 382 s 4; Ex1933 c 27 s 1; 1935 c 266 s 2; 1939 c 160 s 1; 1973 c 638 s 32; 1975 c 136 s 33; 1976 c 222 s 97; 1987 c 108 s 4
MN Stat § 153.17 (2021)
2021 Minnesota Statutes|Chapters 144 - 159 — Health|Chapter 153 — Podiatry|Section 153.17 — Practicing Without License; Penalty.

153.17 PRACTICING WITHOUT LICENSE; PENALTY. Subdivision 1. Unlawful practice of podiatric medicine. It is unlawful for any person not holding a valid license or permit issued in accordance with this chapter to practice podiatric medicine as defined in section 153.01, subdivision 2, in this state. Subd. 2. Practice of podiatric medicine defined. It is unlawful for any person not holding a valid license or permit issued in accordance with this chapter to: (1) advertise, hold out to the public, or represent in any manner that the person is authorized to practice podiatric medicine in this state; (2) use in the conduct of any occupation or profession pertaining to the diagnosis or medical, mechanical, or surgical treatment of the ailments of the human hand, foot, ankle, or soft tissue of the lower leg distal to the tibial tuberosity, the designation "doctor of podiatric medicine," "podiatrist," "DPM," "podiatric physician," "chiropodist," "foot specialist," or "foot doctor," or uses any title, degree, letter, syllable, word, or words that would tend to lead the public to believe that person was authorized to practice or assume duties incident to the practice of podiatric medicine. Subd. 3. Penalty. Any person violating the provisions of subdivision 1 or 2 is guilty of a gross misdemeanor. History:  1987 c 108 s 6; 1999 c 67 s 2